Articles tagged with "drug"

How Rheumatologists Can Connect with Congressional Lawmakers during August Recess

Staff | June 1, 2014

Tips on scheduling in-office meetings in legislators’ home districts and which issues to discuss

Why Tweaking Molecular Structures Can Be Hazardous to Our Health

Simon M. Helfgott, MD | June 1, 2014

The rise and fall of rofecoxib and valdecoxib demonstrate the need for caution in new drug development

Rheumatology Drug Updates, Trials, Safety Data

Michele B. Kaufman, PharmD, BCGP | May 1, 2014

Information on oral anticoagulant apixaban, apremilast for active psoriatic arthritis, hyaluronic acid and methotrexate injections, and drug safety updates rheumatologists need to know

Ethics Forum: The Challenge of Multidisciplinary Care in Rheumatology

Kirk D. Jenkins, MD; Robert H. Shmerling, MD; Rebecca B. Yarrison, PhD; and Kristine M. Lohr, MD, MS | May 1, 2014

A patient with autoimmune ocular disease raises concerns about the moral, professional obligations of rheumatologists to help patients whose condition is not clearly within the scope of rheumatology

Recipients of Ephraim P. Engleman Endowed Resident Research Preceptorship Award in Rheumatology Meet Physician Who Helped Shape Their Careers

From the College | May 1, 2014

Award’s namesake, 103-year-old rheumatologist Ephraim P. Engleman, MD, met 10 winners of research funding established in his name by the Rheumatology Research Foundation in 2006

Fellow’s Forum Case Report: Takayasu’s Arteritis

Ashwini Komarla, MD; Michael George, MD; Antoine Sreih, MD; & Chris Derk, MD, MS | May 1, 2014

How this rare form of large-vessel vasculitis affects different portions, branches of aorta and ways to diagnose, treat and manage the disease

Rheumatology Drug Updates, Trials, Safety Data

Michele B. Kaufman, PharmD, BCGP | April 2, 2014

Information on acetaminophen restrictions; trials for clazakizumab, epratuzumab, romosozumab; and drug safety updates rheumatologists need to know

Tips for Treating Pain, Depression in Patients with Rheumatic Disease Offered at the ACR/ARHP’s 2013 Annual Meeting

Susan Bernstein | April 2, 2014

Observational pain scales, diagnostic tools, pharmacologic interventions, and support from psychologists, caregivers recommended

Global Perspectives on Managing Rheumatoid Arthritis Addressed at the 2013 ACR/ARHP Annual Meeting

Susan Bernstein | April 2, 2014

Poverty, poor access to healthcare, cultural myths present challenges for rheumatologists caring for patients with RA in developing economic regions

Treating Early-Stage Spondyloarthritis May Prevent Disease Progression, Say Researchers at the ACR/ARHP Winter Rheumatology Symposium

Kimberly Retzlaff | April 2, 2014

Therapy with tumor necrosis factor inhibitors, nonsteroidal antiinflammatory drugs, ustekinumab in early stages of osteitis may halt molecular switching to bone-forming phenotype characteristic of SpA